Early in the HIV epidemic, the importance of behavior in the transmission of the virus and the progressionof disease was widely recognized. Behavioral issues remain extremely important in understanding suchcritical aspects of the epidemic as primary and secondary prevention, participation in HIV testing andmedical care, and behavioral aspects of disease progression (e.g., the roles of such variables as adherence,depression and substance abuse on disease; cognitive and psychiatric sequelae of HIV infection).Comprehensive programs of HtV research that can demonstrate the relationships between basic and clinicalscience variables (e.g., patterns of viral resistance, HIV-related morbidity and mortality, or treatment effects)and behavioral variables are necessary for a full understanding of ways to improve outcomes.The overall mission of the Behavioral Sciences Core (BSC) of the UAB CFAR is to make a substantialcontribution to interdisciplinary HIV-related research - whether initiated by behavioral, clinical, basicsciences, epidemiology, or other faculty - and assure a value-added contribution to CFAR throughintegration of behavioral expertise into the fullest range possible of CFAR activities. The BSC's specific aimsare as follows: (1) developing the capacity of behavioral sciences faculty throughout UAB to conceptualizeand implement HIV-related behavioral research projects, including those that are community-, clinically-, andinternationally-based; (2) developing the capacity of non-behavioral sciences faculty, particularly thoseassociated with the UAB CFAR, in the range of behavioral variables, measures, and interventions that maybe incorporated into a comprehensive HIV research program; and (3) facilitating linkages between the CFARand other centers of behavioral expertise within the UAB community, such as the Center for HealthPromotion (CHP).Specific areas of expertise within the BSC include recruitment into clinical or vaccine trials, adherence toantiretroviral therapy and other health recommendations, assessment of behavioral mediators of clinicaloutcomes, community-based HIV prevention and behavioral interventions, the interaction between chemicaldependency and HIV, qualitative data collection and analysis, the prevention of chronic disease risk factorsamong HIV-positive persons, and international HIV prevention and evaluation technology. Integration of theBSC's wide range of behavioral expertise in these areas can allow the UAB CFAR to maintain its reputationas a hub of excellence not only in behavioral, basic and clinical sciences as individual programs, but also inthe development of comprehensive interdisciplinary research that can model the complex interplay of thesevariables in a wide range of populations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI027767-20S1
Application #
7697016
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2008-09-16
Project End
2009-02-28
Budget Start
2008-09-16
Budget End
2009-02-28
Support Year
20
Fiscal Year
2008
Total Cost
$62,350
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Stafman, Laura L; Mruthyunjayappa, Smitha; Waters, Alicia M et al. (2018) Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma. Oncotarget 9:22665-22679
Yang, Zhenhua; Shah, Kushani; Busby, Theodore et al. (2018) Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. J Clin Invest 128:3605-3618
Nag, Mukta; De Paris, Kristina; E Fogle, Jonathan (2018) Epigenetic Modulation of CD8? T Cell Function in Lentivirus Infections: A Review. Viruses 10:
Barr, Fiona D; Ochsenbauer, Christina; Wira, Charles R et al. (2018) Neutrophil extracellular traps prevent HIV infection in the female genital tract. Mucosal Immunol 11:1420-1428
Holdbrooks, Andrew T; Britain, Colleen M; Bellis, Susan L (2018) ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor. J Biol Chem 293:1610-1622
Williams, Adele P; Waters, Alicia M; Stewart, Jerry E et al. (2018) A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro. J Surg Res 228:54-62
Dixit, Saurabh; Sahu, Rajnish; Verma, Richa et al. (2018) Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells. Biomaterials 159:130-145
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372

Showing the most recent 10 out of 955 publications